Close
CDMO Safety Testing 2026
Novotech

ChargePoint Technology and Famat Sampling partner up to create robust containment solution for HPAPI powder transfer

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

FDA Advances Real-Time Clinical Trials With AstraZeneca, Amgen

The U.S. Food and Drug Administration has unveiled a...

Chiesi Advances Rare Disease Portfolio with KalVista Deal

Chiesi Group has entered into a definitive agreement to...

AstraZeneca UK Investment Resumes with ยฃ300m Commitment

In a reversal of its earlier stance, AstraZeneca has...
- Advertisement -

Powder transfer specialist, ChargePoint Technology has joined forces with sampling device specialist, Famat Sampling, to tackle one of the industryโ€™s most challenging containment problems. The pharmaceutical suppliers have created an integrated valve solution capable of allowing operators to take a product sample during the course of the production process for quality analysis while maintaining optimum containment and sterile integrity.ย 

The powerful combination of ChargePoint Technologyโ€™s split butterfly valve and Famat Samplingโ€™s 125-TC/OEL valve creates a secure and sterile environment for high- potency and sterile powder samples to be taken. The interconnected system forms an airtight seal that prevents a dead zone and allows samples of highly potent, toxic or sterile powders to be transferred into containers safely and securely, maintaining OEB4 and OEB5 level compliance.ย 

The integrated network of valves allow for rigorous testing capabilities and ensure that product quality is maintained during the process and it is FDA compliant. The combination of products help minimise risk to the operator, who could be exposed to potentially dangerous powders during the sampling process.ย 

The powder product must not be altered during sampling, as oxygen or other particles could come into contact during the extraction process and damage the product. The combination of technologies from ChargePoint Technology and Famat acts as an isolator and offers users a safe method of transfer so the quality of the product can be protected.ย 

Christian Dunne, Head of Sterile Solutions at ChargePoint Technology, commented on the partnership: โ€œThe HPAPI market is predicted to grow by 8.7%ย  to reach a value of $34.97 billion by 2028 (1), highlighting why itโ€™s vital for drug manufacturers to invest in appropriate containment technologies, as while ensuring they are able to maintain optimum product quality.ย 

โ€œDuring processing, manufacturers must prioritise sampling so that the quality of drug products can be assessed at various stages of the production process. Famat Sampling shares our high standards for quality. Joining forces as two recognised industry leaders in our respective fields was a no-brainer for our team.ย 

โ€œOur shared depth and breadth of knowledge and experience have allowed us to create a solution that helps solve a prevalent issue for manufacturers and adds additional protection for users.โ€ย 

ChargePoint Technology offers containment and aseptic transfer valves and single-use solutions that are essential for the safe transfer of powders during pharmaceutical and biopharmaceutical manufacturing.

Latest stories

Related stories

FDA Advances Real-Time Clinical Trials With AstraZeneca, Amgen

The U.S. Food and Drug Administration has unveiled a...

Chiesi Advances Rare Disease Portfolio with KalVista Deal

Chiesi Group has entered into a definitive agreement to...

AstraZeneca UK Investment Resumes with ยฃ300m Commitment

In a reversal of its earlier stance, AstraZeneca has...

The Science of Regeneration: A Comprehensive Guide to GHK-Cu Peptide

The landscape of regenerative medicine has shifted significantly toward...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป